For Admin

Japanese

A Leading Company in Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

For Absorption

For Vaccination

For Nose-to-Brain

3D Nasal Cast Model

News

2012〜

December 26, 2012

μco™ System is featured in the December 2012 edition of ONdrugDelivery magazine.

November 13, 2012

Results of a Meeting with the US Food and Drug Administration (FDA) Concerning the Development of Intranasal Zolmitriptan for Migraine

October 10, 2012

μco™ System is featured in the September 2012 edition of ONdrugDelivery magazine.

June 7, 2012

SNBL's Fit-lizer™ device is featured in the June 2012 Edition of Drug Development & Delivery Magazine.

May 5, 2012

μco™ System is featured in the April 2012 edition of ONdrugDelivery magazine.

April 4, 2012

Results of First Phase I Clinical Study for Intranasal Zolmitriptan Formulation (Migraine Drug)

February 10, 2011

Conclusion of Licensing Agreement with Pastorus

August 19, 2010

Results of a Meeting with the US Food and Drug Administration (FDA) Concerning the Development of Intranasal Granisetron; Planning for a Phase 3 Study to Improve Patient Quality of Life (QOL)

August 11, 2010

Intranasal Zolmitriptan: Clinical Study of Rapid Acting Migraine Drug - Preparations Underway for US Phase 1 Clinical Study -

May 12, 2010

Research Progress on TR-Flu, an Intranasal Flu Vaccine in Dry Powder Form (First Report)

2024｜2023｜2022｜2021 ｜2020｜2019｜2018｜2016｜2015｜2014｜2013｜2012〜